1. Home
  2. GEN vs NTRA Comparison

GEN vs NTRA Comparison

Compare GEN & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEN
  • NTRA
  • Stock Information
  • Founded
  • GEN 1982
  • NTRA 2003
  • Country
  • GEN United States
  • NTRA United States
  • Employees
  • GEN N/A
  • NTRA N/A
  • Industry
  • GEN Computer Software: Prepackaged Software
  • NTRA Medical Specialities
  • Sector
  • GEN Technology
  • NTRA Health Care
  • Exchange
  • GEN Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • GEN 18.9B
  • NTRA 21.9B
  • IPO Year
  • GEN N/A
  • NTRA 2015
  • Fundamental
  • Price
  • GEN $30.61
  • NTRA $138.90
  • Analyst Decision
  • GEN Buy
  • NTRA Strong Buy
  • Analyst Count
  • GEN 5
  • NTRA 16
  • Target Price
  • GEN $33.60
  • NTRA $185.56
  • AVG Volume (30 Days)
  • GEN 3.4M
  • NTRA 1.3M
  • Earning Date
  • GEN 08-07-2025
  • NTRA 08-07-2025
  • Dividend Yield
  • GEN 1.63%
  • NTRA N/A
  • EPS Growth
  • GEN 8.42
  • NTRA N/A
  • EPS
  • GEN 1.03
  • NTRA N/A
  • Revenue
  • GEN $3,935,000,000.00
  • NTRA $1,831,000,000.00
  • Revenue This Year
  • GEN $21.45
  • NTRA $19.75
  • Revenue Next Year
  • GEN $5.06
  • NTRA $16.04
  • P/E Ratio
  • GEN $29.72
  • NTRA N/A
  • Revenue Growth
  • GEN 3.55
  • NTRA 51.50
  • 52 Week Low
  • GEN $22.74
  • NTRA $92.14
  • 52 Week High
  • GEN $31.72
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • GEN 60.56
  • NTRA 30.96
  • Support Level
  • GEN $29.64
  • NTRA $136.91
  • Resistance Level
  • GEN $30.82
  • NTRA $142.49
  • Average True Range (ATR)
  • GEN 0.46
  • NTRA 5.08
  • MACD
  • GEN 0.03
  • NTRA -1.82
  • Stochastic Oscillator
  • GEN 90.32
  • NTRA 7.18

About GEN Gen Digital Inc.

Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: